editor
rhinoviru
rv
human
bocaviru
common
caus
respiratori
tract
infect
earli
childhood
rv
rna
viru
caus
recurr
infect
new
strain
dna
viru
may
caus
prolong
shed
mostli
found
simultan
respiratori
virus
virus
associ
earli
wheez
rv
detect
approxim
case
acut
infect
serodiagnos
case
coinfect
detect
case
unlik
rv
wheez
wheez
link
increas
risk
asthma
earli
childhood
asthma
atopi
children
close
interrel
increas
h
cell
decreas
type
iiiiii
interferon
ifn
respons
suscept
rv
infect
less
known
bronchiol
associ
balanc
h
h
respons
nasopharyng
mucosa
whether
cytokin
respons
reflect
immun
host
speci
viru
unclear
interestingli
clone
inhibit
sendai
virusinduc
ifn
product
vitro
suggest
may
also
affect
host
respons
virus
vivo
howev
vivo
data
viru
interfer
respiratori
viru
human
lack
object
studi
compar
system
h
h
proinflammatori
cytokin
profil
young
children
sole
rvor
sole
wheez
moreov
want
investig
whether
codetect
rv
would
associ
differ
cytokin
respons
would
detect
either
viru
alon
present
studi
includ
children
cohort
first
second
wheezi
episod
sole
rv
n
sole
n
combin
infect
without
evid
virus
n
studi
protocol
approv
ethic
committe
turku
univers
hospit
inform
consent
obtain
guardian
commenc
studi
hospit
admiss
respiratori
virus
test
viru
cultur
done
adenoviru
enterovirus
rv
influenza
b
virus
human
metapneumoviru
parainfluenza
viru
type
respiratori
syncyti
viru
viral
antigen
detect
adenoviru
influenza
b
virus
respiratori
syncyti
viru
level
specif
igg
antibodi
measur
pair
serum
sampl
adenoviru
enterovirus
influenza
b
virus
parainfluenza
viru
pcr
use
detect
adenoviru
coronavirus
enterovirus
rv
includ
rvc
speci
influenza
b
virus
metapneumoviru
respiratori
syncyti
viru
parainfluenza
viru
acut
infect
serolog
confirm
serum
taken
studi
entri
analyz
follow
cytokin
use
human
cytokin
linco
plex
kit
millipor
corpor
billerica
mass
sensit
cytokin
shown
tabl
articl
onlin
repositori
www
jacionlineorg
gmcsf
ifng
tnfa
children
follow
year
time
recurr
wheez
assess
previous
defin
normal
data
distribut
test
use
kolmogorovsmirnov
test
skew
data
cytokin
level
log
transform
statist
test
mannwhitney
u
test
x
test
anova
kruskalw
test
logrank
test
cox
proport
hazard
ratio
test
use
appropri
pasw
softwar
spss
inc
chicago
ill
mean
age
whole
cohort
year
slight
male
predomin
sensit
detect
patient
allergenspecif
ige
kul
common
allergen
phadiatop
combi
phadia
uppsala
sweden
children
first
wheezi
episod
parent
asthma
report
children
longterm
control
medic
recurr
wheez
initi
children
followup
within
first
year
patient
characterist
differ
viru
group
see
tabl
articl
onlin
repositori
wwwjacionlineorg
wheez
children
rv
higher
proinflammatori
h
h
respons
fig
interestingli
differ
cytokin
level
found
coinfect
group
cytokin
respons
seen
rv
group
gener
lower
group
fig
ifng
level
differ
studi
group
ratio
higher
respect
p
rv
group
group
otherwis
differ
cytokin
respons
detect
viru
group
sensit
children
lower
ifng
level
lower
ratio
higher
ratio
nonsensit
children
p
see
tabl
articl
onlin
repositori
wwwjacionlineorg
repeat
viru
group
comparison
without
sensit
children
signific
differ
persist
except
ratio
data
shown
wheez
children
rv
trend
develop
recurr
wheez
often
sooner
hbov
infect
p
fig
see
also
tabl
studi
show
import
find
first
unlik
rv
associ
system
proinflammatori
h
cytokin
respons
acut
wheez
interestingli
coinfect
rv
result
modifi
nont
h
cytokin
respons
find
togeth
previou
vitro
data
suggest
may
interfer
rvinduc
immun
respons
immunolog
respons
accompani
clinic
find
children
combin
wheez
tend
develop
recurr
wheez
later
less
often
rv
wheez
sever
rv
infect
known
relat
atop
statu
understand
mechan
infect
may
open
new
target
tackl
rvassoci
undesir
event
recurr
wheez
asthma
develop
second
sensit
children
higher
lower
ratio
consist
atop
inflamm
chang
similar
report
rv
infect
although
abl
show
signific
link
rv
atopi
find
fit
hypothesi
earli
h
inflamm
exist
rv
wheez
sensit
detect
altogeth
find
suggest
immunolog
respons
acut
wheez
depend
host
atopyrel
inflamm
virusspecif
factor
virusviru
interact
may
signific
modul
respons
incid
recurr
wheez
young
children
rv
n
n
combin
n
associ
wheez
data
express
percentag
children
recurr
wheez
studi
entri
data
analyz
use
logrank
test
overal
comparison
p
rv
vs
p
rv
vs
p
children
sever
asthma
uniqu
oxid
stressassoci
metabolom
profil
editor
children
sever
asthma
challeng
group
patient
extrem
difficult
treat
although
inhal
corticosteroid
ic
cornerston
asthma
treatment
children
sever
asthma
decreas
respons
highdos
corticosteroid
therapi
associ
airway
inflamm
remodel
given
limit
efficaci
corticosteroid
sever
asthma
effort
focus
role
oxid
stress
name
thiol
redox
disturb
modul
disord
inde
previous
demonstr
greater
oxid
decreas
concentr
thiol
cystein
glutathion
airway
system
circul
children
sever
asthma
associ
increas
airway
inflamm
impair
cellular
function
recogn
treatment
sever
asthma
might
ultim
requir
novel
approach
restor
corticosteroid
sensit
perform
metabolom
analys
plasma
sampl
highli
character
sampl
children
sever
asthma
treat
highdos
ic
longact
beta
agonist
children
mildtomoder
asthma
treat
ic
icslongact
beta
agonist
combin
therapi
report
children
sever
asthma
differenti
metabol
pathway
associ
oxid
stress
glycin
serin
threonin
metabol
pathway
nacylethanolamin
nacyltransferas
pathway
find
support
biolog
plausibl
oxid
stress
contributori
factor
corticosteroid
insensit
sever
asthma
potenti
highlight
novel
therapeut
target
confirm
studi
valu
express
mean
sd
n
overal
differ
viru
group
test
use
chisquar
test
p
allergenspecif
ige
kul
studi
entri
p
overal
group
comparison
valu
pgml
express
median
interquartil
rang
iqr
signific
differ
shown
ital
allergenspecif
ige
kul
common
allergen
phadiatop
combi
phadia
uppsala
sweden
